"Marketing meeting at Novartis probably went..." or Help Yourself, by Alison Fisher http://www.facebook.com/photo.php?fbid=3897657798332&set=a.3475436083053.2160140.1185729368&type=1&theater&notif_t=photo_reply


Foto's van Alison Fisher
Marketing meeting at Novartis probably went like this ".....so no good for kidney patients... lets rework the stats, rebrand it as Gilenya and give it to that favoured dumping ground for recycled drugs.... MS patients... we can get away with giving them anything whether it stops their hearts, gives them cancer, macular edema....."

The European Medicines Agency says it should not be prescribed to patients with CEREBROVASCULAR PROBLEMS... ie problems with blood flow to the brain.... oops..
Various